Research ArticleOriginal Article
Open Access

Prevalence and biopsychosocial factors associated with treatment adherence among people with epilepsy in a tertiary care hospital in Riyadh, Saudi Arabia

Amani S. Almwled, Abdulkarim O. Almuhaydili, Saqr M. Altamimi, Muhannad A. Alzahrani, Rodhan K. Alnahdi, Saad B. Almotairi, Bandar N. Aljafen and Fahad D. Alosaimi
Neurosciences Journal April 2022, 27 (2) 94-103; DOI: https://doi.org/10.17712/nsj.2022.2.20210142

References

  1. 1.↵
    Epilepsy. [Cited9 February 2022; Updated 17th April 2022]. Available from: https://www.who.int/news-room/fact-sheets/detail/epilepsy
  2. 2.↵
    1. Benamer HTS,
    2. Grosset DG.
    A systematic review of the epidemiology of epilepsy in Arab countries. Epilepsia 2009; 50: 2301–2304.
    OpenUrl
  3. 3.↵
    1. Al Rajeh S,
    2. Awada A,
    3. Bademosi O,
    4. Ogunniyi A.
    The prevalence of epilepsy and other seizure disorders in an Arab population: A community-based study. Seizure 2001; 10: 410–414.
    OpenUrlPubMed
  4. 4.↵
    1. Hamdy NA,
    2. Alamgir MJ,
    3. Mohammad EGE,
    4. Khedr MH,
    5. Fazili S.
    Profile of Epilepsy in a Regional Hospital in Al Qassim, Saudi Arabia. Int J Health Sci (Qassim) 2014; 8: 247–255.
    OpenUrl
  5. 5.↵
    1. O’Donoghue MF,
    2. Sander JWAS.
    The Mortality Associated with Epilepsy, with Particular Reference to Sudden Unexpected Death: A Review. Epilepsia 1997; 38: S15–S19.
    OpenUrlPubMed
  6. 6.↵
    1. Thurman DJ,
    2. Logroscino G,
    3. Beghi E,
    4. Hauser WA,
    5. Hesdorffer DC,
    6. Newton CR, et al.
    The burden of premature mortality of epilepsy in high-income countries: A systematic review from the Mortality Task Force of the International League Against Epilepsy. Epilepsia 2017; 58: 17–26.
    OpenUrlPubMed
  7. 7.↵
    1. Kwon OY,
    2. Park SP.
    Depression and anxiety in people with epilepsy. J Clin Neurol 2014; 10: 175–188.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. McAuley JW,
    2. Passen N,
    3. Prusa C,
    4. Dixon J,
    5. Cotterman-Hart S,
    6. Shneker BF.
    An evaluation of the impact of memory and mood on antiepileptic drug adherence. Epilepsy Behav 2015; 43: 61–65.
    OpenUrl
  9. 9.
    1. Tellez-Zenteno JF,
    2. Patten SB,
    3. Jetté N,
    4. Williams J,
    5. Wiebe S.
    Psychiatric Comorbidity in Epilepsy: A Population-Based Analysis. Epilepsia 2007; 48: 2336–2344.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Gaitatzis A,
    2. Trimble MR,
    3. Sander JW.
    The psychiatric comorbidity of epilepsy. Acta Neurol Scand 2004; 110: 207–220.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Mroueh L,
    2. Boumediene F,
    3. Jost J,
    4. Ratsimbazafy V,
    5. Preux PM,
    6. Salameh P, et al.
    Self-reported attitudes about medication in Lebanese people with epilepsy. Epilepsy Behav 2019; 98: 80–87.
    OpenUrl
  12. 12.
    1. Tareke M,
    2. Birehanu M,
    3. Amare D,
    4. Abate A.
    Common mental illness among epilepsy patients in Bahir Dar city, Ethiopia: A cross-sectional study. PLoS One 2020; 15: e0227854.
    OpenUrl
  13. 13.↵
    1. Mohammed HG,
    2. Hafez MK.
    Factors associated with medication adherence among epileptic patients. International Journal of Novel Research in Healthcare and Nursing 2019; 3: 396–407.
    OpenUrl
  14. 14.↵
    WHO. Adherence to long-term therapies: evidence for action / [edited by Eduardo Sabaté] [Internet]. Geneva PP - Geneva (CH): World Health Organization; [cited 2021 Mar 15]. Available from: https://www.who.int/chp/knowledge/publications/adherence_report/en/
  15. 15.↵
    1. Elger CE,
    2. Schmidt D.
    Modern management of epilepsy: A practical approach. Epilepsy Behav 2008; 12: 501–539.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Malek N,
    2. Heath CA,
    3. Greene J.
    A review of medication adherence in people with epilepsy. Acta Neurol Scand 2017; 135-: 507–515.
    OpenUrlPubMed
  17. 17.↵
    1. Zafar A,
    2. Shahid R,
    3. Nazish S,
    4. Aljaafari D,
    5. Alkhamis FA,
    6. Alsalman S, et al.
    Nonadherence to antiepileptic medications: Still a major issue to be addressed in the management of epilepsy. J Neurosci Rural Pract 2019; 10: 106–112.
    OpenUrl
  18. 18.↵
    1. Gabr WM,
    2. Shams MEEE.
    Adherence to medication among outpatient adolescents with epilepsy. Saudi Pharm J 2015; 23: 33–40.
    OpenUrl
  19. 19.↵
    1. Manjunath R,
    2. Davis KL,
    3. Candrilli SD,
    4. Ettinger AB.
    Association of antiepileptic drug nonadherence with risk of seizures in adults with epilepsy. Epilepsy Behav 2009; 14: 372–378.
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    1. Davis KL,
    2. Candrilli SD,
    3. Edin HM.
    Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population. Epilepsia 2008; 49: 446–454.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Faught E,
    2. Duh MS,
    3. Weiner JR,
    4. Guérin A,
    5. Cunnington MC.
    Nonadherence to antiepileptic drugs and increased mortality. Neurology 2008; 71: 1572.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Guo Y,
    2. Ding XY,
    3. Lu RY,
    4. Shen CH,
    5. Ding Y,
    6. Wang S, et al.
    Depression and anxiety are associated with reduced antiepileptic drug adherence in Chinese patients. Epilepsy Behav 2015; 50: 91–95.
    OpenUrl
  23. 23.↵
    1. Shallcross AJ,
    2. Becker DA,
    3. Singh A,
    4. Friedman D,
    5. Jurd R,
    6. French JA, et al.
    Psychosocial factors associated with medication adherence in ethnically and socioeconomically diverse patients with epilepsy. Epilepsy Behav 2015; 46: 242–245.
    OpenUrl
  24. 24.↵
    1. O’ Rourke G,
    2. O’ Brien JJ.
    Identifying the barriers to antiepileptic drug adherence among adults with epilepsy. Seizure 2017; 45: 160–168.
    OpenUrl
  25. 25.↵
    1. Ettinger AB,
    2. Good MB,
    3. Manjunath R,
    4. Edward Faught R,
    5. Bancroft T.
    The relationship of depression to antiepileptic drug adherence and quality of life in epilepsy. Epilepsy Behav 2014; 36: 138–143.
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    1. Wang S,
    2. Chen C,
    3. Jin B,
    4. Yang L,
    5. Ding Y,
    6. Guo Y, et al.
    The association of psychosocial variables with adherence to antiepileptic drugs in patients with temporal lobe epileps. Epilepsy Behav 2017; 77: 39–43.
    OpenUrl
  27. 27.↵
    1. Sockalingam S,
    2. Blank D,
    3. Abdelhamid N,
    4. Abbey SE,
    5. Hirschfield GM.
    Identifying opportunities to improve management of autoimmune hepatitis: Evaluation of drug adherence and psychosocial factors. J Hepatol 2012; 57: 1299–1304.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Ciechanowski P,
    2. Russo J,
    3. Katon W,
    4. Von Korff M,
    5. Ludman E,
    6. Lin E, et al.
    Influence of Patient Attachment Style on Self-care and Outcomes in Diabetes. Psychosom Med 2004; 66(5): 720–728.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    1. Sockalingam S,
    2. Cassin S,
    3. Hawa R,
    4. Khan A,
    5. Wnuk S,
    6. Jackson T, et al.
    Predictors of post-bariatric surgery appointment attendance: The role of relationship style. Obes Surg 2013; 23: 2026–2032.
    OpenUrl
  30. 30.↵
    1. Alosaimi FD,
    2. AlMulhem A,
    3. AlShalan H,
    4. Alqazlan M,
    5. Aldaif A,
    6. Kowgier M, et al.
    Psychosocial predictors of patient adherence to disease-modifying therapies for multiple sclerosis. Patient Prefer Adherence 2017; 11: 513–518.
    OpenUrl
  31. 31.↵
    1. Al-Khateeb JM,
    2. Al-Khateeb AJ.
    Research on psychosocial aspects of epilepsy in Arab countries: A review of literature. Epilepsy Behav 2014; 31: 256–262.
    OpenUrl
  32. 32.↵
    1. Brown C.
    Pharmacological management of epilepsy. Prog Neurol Psychiatry 2016; 20: 27–34c.
    OpenUrl
  33. 33.↵
    1. Kalichman SC,
    2. Amaral CM,
    3. Swetzes C,
    4. Jones M,
    5. MacY R,
    6. Kalichman MO, et al.
    A simple single-item rating scale to measure medication adherence: Further evidence for convergent validity. J Int Assoc Physicians AIDS Care (Chic) 2009; 8: 367–374.
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Finitsis DJ,
    2. Pellowski JA,
    3. Huedo-Medina TB,
    4. Fox MC,
    5. Kalichman SC.
    Visual analogue scale (VAS) measurement of antiretroviral adherence in people living with HIV (PLWH): a meta-analysis. J Behav Med 2016; 39: 1043–1055.
    OpenUrl
  35. 35.↵
    1. Zeller A,
    2. Ramseier E,
    3. Teagtmeyer A,
    4. Battegay E.
    Patients’ self-reported adherence to cardiovascular medication using electronic monitors as comparators. Hypertens Res 2008; 31: 2037–2043.
    OpenUrlCrossRefPubMed
  36. 36.
    1. Gallagher BD,
    2. Muntner P,
    3. Moise N,
    4. Lin JJ,
    5. Kronish IM.
    Are two commonly used self-report questionnaires useful for identifying antihypertensive medication nonadherence? J Hypertens 2015; 33: 1108–1113.
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. Alosaimi FD,
    2. Asiri M,
    3. Alsuwayt S,
    4. Alotaibi T,
    5. Bin Mugren M,
    6. Almufarrih A, et al.
    Psychosocial predictors of nonadherence to medical management among patients on maintenance dialysis. Int J Nephrol Renovasc Dis 2016; 9: 263–272.
    OpenUrl
  38. 38.↵
    1. Kroenke K,
    2. Spitzer RL,
    3. Williams JBWW.
    The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 606–613.
    OpenUrlCrossRefPubMedWeb of Science
  39. 39.↵
    1. Spitzer RL,
    2. Kroenke K,
    3. Williams JBWW,
    4. Löwe B.
    A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch Intern Med 2006; 166: 1092–1097.
    OpenUrlCrossRefPubMedWeb of Science
  40. 40.↵
    1. Kroenke K,
    2. Spitzer RL,
    3. Williams JBWW.
    The PHQ-15: Validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002; 64: 258–266.
    OpenUrlAbstract/FREE Full Text
  41. 41.↵
    1. Sha MC,
    2. Callahan CM,
    3. Counsell SR,
    4. Westmoreland GR,
    5. Stump TE,
    6. Kroenke K.
    Physical symptoms as a predictor of health care use and mortality among older adults. Am J Med 2005; 118: 301–306.
    OpenUrlCrossRefPubMedWeb of Science
  42. 42.↵
    1. Brennan KA,
    2. Clark CL,
    3. Shaver PR,
    4. Simpson JA,
    5. Rholes WS.
    Attachment theory and close relationships. 1998; New York (NY): Guilford Press. pp.46–76
  43. 43.↵
    1. Nasreddine ZS,
    2. Phillips NA,
    3. Bédirian V,
    4. Charbonneau S,
    5. Whitehead V,
    6. Collin I, et al.
    The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53: 695–699.
    OpenUrlCrossRefPubMedWeb of Science
  44. 44.↵
    1. Eddy CM,
    2. Rickards HE,
    3. Cavanna AE.
    The cognitive impact of antiepileptic drugs. Ther Adv Neurol Disord 2011; 4: 385–407.
    OpenUrlCrossRefPubMed
  45. 45.
    1. Gillham R,
    2. Kane K,
    3. Bryant-Comstock L,
    4. Brodie MJ.
    A double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy with health-related quality of life as an outcome measure. Seizure 2000; 9: 375–379.
    OpenUrlCrossRefPubMedWeb of Science
  46. 46.
    1. Meador KJ.
    Cognitive and memory effects of the new antiepileptic drugs. Epilepsy Res 2006; 68: 63–67.
    OpenUrlCrossRefPubMedWeb of Science
  47. 47.↵
    1. Edwards KR,
    2. Sackellares JC,
    3. Vuong A,
    4. Hammer AE,
    5. Barrett PS.
    Lamotrigine Monotherapy Improves Depressive Symptoms in Epilepsy: A Double-Blind Comparison with Valproate. Epilepsy Behav 2001; 2: 28–36.
    OpenUrlCrossRefPubMed
  48. 48.↵
    1. Tellez-Zenteno JF,
    2. Matijevic S,
    3. Wiebe S.
    Somatic Comorbidity of Epilepsy in the General Population in Canada. Epilepsia 2005; 46: 1955–1962.
    OpenUrlCrossRefPubMedWeb of Science
  49. 49.↵
    1. Plioplys S,
    2. Doss J,
    3. Siddarth P,
    4. Bursch B,
    5. Falcone T,
    6. Forgey M
    , et al. Risk factors for comorbid psychopathology in youth with psychogenic nonepileptic seizures. Seizure 2016; 38: 32–37.
    OpenUrl
  50. 50.↵
    1. Elsayed M,
    2. El-Sayed N,
    3. Badi S,
    4. Ahmed M.
    Factors affecting adherence to antiepileptic medications among Sudanese individuals with epilepsy: A cross-sectional survey. J Family Med Prim Care 2019; 8: 2312.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section